Browse Storyflo.Across every vertical.

Politico·policy·7 min

Hospitals are taking the fall for high health care costs

Drugmakers and insurers are shifting blame onto hospitals for rising healthcare costs, seeking to protect their own profits amid growing scrutiny from lawmakers. They argue that regulating hospitals is key to making healthcare more affordable, while hospitals face potential cuts to Medicaid and Medicare payments. This blame game comes as hospitals are already grappling with the financial impacts of consolidation and increased costs. Recent lobbying efforts have intensified, with drugmakers launching ad campaigns accusing hospitals of misusing federal drug discount programs. Insurers are also pushing narratives that hospital consolidation is driving prices up. The competition among these powerful lobbies has led to bipartisan agreement among some nonprofits, which traditionally hold opposing views, on the need to address hospital pricing and consolidation. Hospital representatives express concern that they are losing influence as lawmakers focus on the financial practices of large hospital systems, which have been linked to rising healthcare spending. The Trump administration is considering changes to the 340B drug discount program, which allows hospitals serving low-income patients to purchase medications at reduced prices. Drugmakers claim the program is being abused, and recent investigations have prompted calls for reform. As the healthcare landscape evolves, hospitals are facing an increasingly challenging economic environment, compounded by significant cuts to Medicaid and the expiration of enhanced subsidies under the Affordable Care Act. With the Trump administration signaling support for reforms that could further impact hospital funding, the outlook for hospitals remains precarious, as they navigate mounting pressure from both industry rivals and policymakers.